Agios Pharmaceuticals, Inc.

Healthcare · Biotechnology · United States

Last price 30.55 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.82B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency. The company’s PYRUKYND product is also used for the treatment of sickle cell disease that is in phase 3 clinical trial; for the treatment of PK deficiency in pediatric patients; and AQVESME for the treatment of a...